hepha2 (R&D Systems Hematology)
Structured Review
Hepha2, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 94/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepha2/Recombinant+Human+EphA2+Protein%2C+CF/pmc08253144-65-5-6
Average 94 stars, based on 22 article reviews
Images
Related Articles
Activation Assay:Article Title: RASA2 deletion rescues immune synapse dysfunction, enhancing CAR T cell efficacy against DMGs. Article Snippet: .. Antigen-coated coverslip preparation and CAR T cell activation Antigen- coated coverslips were prepared using N1 coverslips (Thermo Fisher Scientific; 12- 545- 80P), which were coated with 0.5 μg/mL of Recombinant:Article Title: Synthetic antibodies targeting EphA2 induce diverse signaling‐competent clusters with differential activation Article Snippet: .. Article Title: Synthetic antibodies targeting EphA2 induce diverse signaling-competent clusters with differential activation. Article Snippet: .. Article Title: Bispecific Ligand-Based EphB4 CAR-T Cells Generated Using Ephrin-B2 Show Potent Antitumor Activity Against Lung Adenocarcinoma. Article Snippet: .. For cytokine and T cell quantification, recombinant human EphB4 Fc chimera protein (CF) and Article Title: Dual generation of stereo- and linear-specific monoclonal antibodies through B-cell receptors by DNA and cell immunization for therapeutic applications. Article Snippet: The optimized stereospecific targeting (SST) technique features selective generation of conformation-specific monoclonal antibodies against membranous proteins with high specificity after DNA and cell immunization.. This technology consists of two critical steps, which are specific selection of sensitized B lymphocytes by antigen-expressing myeloma cells through Bcell receptors (BCRs) and selective fusion of B cell-myeloma cell complexes by electrical pulses to produce hybridoma cells secreting stereospecific monoclonal antibodies.. Here we were able to verify the critical step for the selection of B lymphocytes by intact antigen-expressing myeloma cells by a double-label immunofluorescence analysis. |

